Anaemia management in patients with chronic kidney disease: Taiwan practice guidelines

Autor:	Ko Lin Kuo, Der Cherng Tarng, Tung Po Huang, Chih Cheng Hsu, Mai Szu Wu, Szu Chun Hung
Rok vydání:	2014
Předmět:	medicine.medical_specialty Creatinine Dose medicine.diagnostic_test Transferrin saturation business.industry medicine.medical_treatment General Medicine Iron deficiency Hematocrit medicine.disease law.invention Surgery chemistry.chemical_compound Randomized controlled trial chemistry Nephrology law hemic and lymphatic diseases Internal medicine medicine business Dialysis Kidney disease
Zdroj:	Nephrology. 19:735-739
ISSN:	1320-5358
Popis:	The introduction of erythropoiesis-stimulating agents (ESAs) markedly improved the lives of many anaemic patients with chronic kidney disease (CKD). In Taiwan, the strategy of management of anaemia in patients with CKD was different from many other parts of the world. In 1996, the National Health Insurance Administration of Taiwan applied a more restrictive reimbursement criteria for ESA use in patients with CKD. ESA is to be initiated when non-dialysis CKD patients have a serum creatinine >6 mg/dL and a hematocrit
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::9a8369386c11be0f1f8a294932410e89 https://doi.org/10.1111/nep.12332 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.